The Therapeutic Efficacy Conferred by the 5-HT1A Receptor Agonist 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) after Experimental Traumatic Brain Injury Is Not Mediated by Concomitant Hypothermia

Journal of Neurotrauma

Volumn 21, Issue 2, 2004, Pages 175-185

  Kline, Anthony E ^a,b   Massucci, Jaime L ^a,b,c   Dixon, C Edward ^a,b   Zafonte, Ross D ^a   Bolinger, Bryan D ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

8 OH DPAT; Controlled cortical impact (CCI); Function; Learning; Memory; Morris water maze (MWM); Recovery

Indexed keywords

2 DIBUTYLAMINO 8 HYDROXYTETRALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; BRAIN SIZE; CELL LOSS; CELL SURVIVAL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORE TEMPERATURE; DRUG EFFECT; DRUG EFFICACY; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOTHERMIA; LEARNING; MALE; MAZE TEST; MOTOR PERFORMANCE; NEUROPHARMACOLOGY; NEUROPROTECTION; NONHUMAN; RAT; TASK PERFORMANCE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACUTE DISEASE; ANIMALS; BODY TEMPERATURE; BRAIN INJURIES; CELL SURVIVAL; CEREBRAL CORTEX; COGNITION; HIPPOCAMPUS; HYPOTHERMIA, INDUCED; MALE; MAZE LEARNING; MOTOR ACTIVITY; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECOVERY OF FUNCTION; SEROTONIN AGONISTS;

EID: 1242298538     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771504322778631     Document Type: Article

References (56)

1. ALESSANDRI, B., TSUCHIDA, E., and BULLOCK, R.M. (1999). The neuroprotective effect of a new serotonin receptor agonist, BAY x3702, upon focal ischemic brain damage caused by acute subdural hematoma in the rat. Brain Res. 845, 232-235.
2. 1A receptors in the rat hippocampus and cortex. Drug Dev. Res. 26, 275-286.
3. BARNES, N.M., and SHARP, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152.
4. BARTUS, R.T., DEAN, R.L., BEER, B., et al. (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
5. BRAMLETT, H.M., GREEN, E.J., and DIETRICH, W.D. (1997). Hippocampally dependent and independent chronic spatial navigational deficits following parasagittal fluid percussion brain injury in the rat. Brain Res. 762, 195-202.
6. BULLOCK, R., CHESNUT, R.M. CLIFTON, G., et al. (2000). Guidelines for the management of severe head injury: Brain Trauma Foundation. J. Neurotrauma 17, 449-627.
7. BURGER R., ZUECHNER, M., BENDSZUS, M., et al. (2003). Moderate hypothermia improves neurobehavioral deficits after an epidural focal mass lesion in rodents. J. Neurotrauma 20, 543-558.
8. CIALLELLA, J.R., YAN, H.Q., MA, X., et al. (1998). Chronic effects of traumatic brain injury on hippocampal vesicular acetylcholine transporter and M2 muscarinic receptor protein in rats. Exp. Neurol. 152, 11-19.
9. CLARK, R.S.B., KOCHANEK, P.M., MARION, D.W., et al. (1996). Mild posttraumatic hypothermia reduces mortality after severe controlled cortical impact in rats. J. Cereb. Blood Flow Metab. 16, 252-261.
10. CLIFTON, G.L., ALLEN, S., BARRODALE, P., et al. (1993). A phase 11 study of moderate hypothermia in severe brain injury. J. Neurotrauma 10, 263-271.
11. CLIFTON, G.L., JIANG, J.Y., LYETH, B.G., et al. (1991). Marked protection by moderate hypothermia after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 11, 114-121.
12. CLIFTON, G.L., MILLER, E.R., CHOI, S.C., et al. (2001). Lack of effect of induction of hypothermia after acute brain injury. N. Engl. J. Med. 344, 556-563.
13. 1A receptor antagonist WAY 100635. J. Psychopharmacol. 13, 278-283.
14. DE VRY J., DIETRICH H., GLASER T., et al. (1997). BAY x 3702. Drugs of the Future 22, 341-349.
15. 1A receptor agonist BAY x 3702 in the rat. Eur. J. Pharmacol. 357, 1-8.
16. 1A receptor agonist. J. Pharmacol. Exp. Ther. 284, 1082-1094.
17. DIXON, C.E., BAO, J., JOHNSON, K.M., et al. (1995). Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats. Neurosci. Lett. 198, 111-114.
18. DIXON, C.E., CLIFTON, G.L., LIGHTHALL, J.W., et al. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253-262.
19. DIXON, C.E., KRAUS, M.F., KLINE, A.E., et al. (1999). Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. Restor. Neurol. Neurosci. 14, 285-294.
20. DIXON, C.E., MA, X., and MARION, D.W. (1997). Reduced evoked release of acetylcholine in the rodent neocortex following traumatic brain injury. Brain Res. 749, 127-130.
21. DIXON, C.E., MARKGRAF, C.G., ANGILERI, F., et al. (1998). Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat. J. Neurotrauma 15, 95-103.
22. FEENEY, D.M., GONZALEZ, A., and LAW, W.A. (1982). Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217, 855-857.
23. FUJII, T., YOSHIZAWA, M., NAKAI, K., et al. (1997). Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. Brain Res. 761, 244-249.
24. HAMM, R.J., DIXON, C.E., GBADEBO, D.M., et al. (1992). Cognitive deficits following traumatic brain injury produced by controlled cortical impact. J. Neurotrauma 9, 11-20.
25. HAMM, R.J., TEMPLE, M.D., PIKE, B.R., et al. (1996). Working memory deficits following traumatic brain injury in the rat. J. Neurotrauma 13, 317-323.
26. HJORTH, S. (1985). Hypothermia in the rat induced by the potent serotonergic agent 8-OH-DPAT. J. Neural Transm. 61, 131-135.
27. KLINE, A.E., BOLINGER, B.D., KOCHANEK, P.M., et al. (2002b). Acute systemic administration of interleukin-10 suppresses the beneficial effects of moderate hypothermia following traumatic brain injury in rats. Brain Res. 937, 22-31.
28. KLINE, A.E., and DIXON, C.E. (2001). Contemporary in vivo models of brain trauma and a comparison of injury responses, in: Head Trauma: Basic, Preclinical and Clinical Directions. L.P. Miller and R.L. Hayes (eds). Wiley: New York, pps. 65-84.
29. KLINE, A.E., YAN, H.Q., BAO, J., et al. (2000). Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci. Lett. 280, 163-166.
30. 1A receptor agonist Repinotan HCL attenuates histopathology and spatial learning deficits following traumatic brain injury in rats. Neuroscience 106, 547-555.
31. 1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) against traumatic brain injury-induced cognitive deficits and neuropathology in adult male rats. Neurosci. Lett. 333, 179-182.
32. KOCHANEK, P.M., and SAFAR, P.J. (2003). Therapeutic hypothermia for severe traumatic brain injury. JAMA 289, 3007-3009.
33. KOIZUMI, H., and POVLISHOCK, J.T. (1998). Posttraumatic hypothermia in the treatment of axonal damage in an animal model of traumatic axonal injury. J. Neurosurg. 89, 303-309.
34. KOYAMA, T., NAKAJIMA, Y., FUJII, T., et al. (1999). Enhancement of cortical and hippocampal cholinergic neurotransmission through 5-HT1A receptor-mediated pathways by BAY x 3702 in freely moving rats. Neurosci. Lett. 265, 33-36.
35. LYETH, B.G., JIANG, J.Y., and LIU, S. (1993). Behavioral protection by moderate hypothermia initiated after experimental traumatic brain injury. J. Neurotrauma 10, 57-64.
36. MARION, D.W. PENROD, L.E., KELSEY, S.F., et al. (1997). Treatment of traumatic brain injury with moderate hypothermia. N. Engl. J. Med. 336, 540-546.
37. 1A receptors in guinea pig dentate gyrus. Brain Res. 728, 175-180.
38. 1A receptor agonist BAY x 3702 in vitro and in vivo. Brain Res. 888, 150-157.
39. McINTYRE, L.A., FERGUSSON, D.A., HÉBERT, P.C., et al. (2003). Prolonged therapeutic hypothermia after traumatic brain injury in adults. JAMA 289, 2992-2999.
40. McINTOSH, T.K., YU, T., and GENNARELLI, T.A. (1994). Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J. Neurochem. 63, 1426-1433.
41. 1A receptor agonist 8-OH-DPAT: possible significance for neuroprotection. Eur. J. Pharmacol. 406, 319-324.
42. MENESES, A. (1999). 5-HT system and cognition. Neurosci. Biobehav. Rev. 23, 1111-1125.
43. MILLAN, M.J., RIVET, J.M., CANTON, H., et al. (1993). Induction of hypothermia as a model of 5-hydroxytryptamine 1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists. J. Pharmacol. Exp. Ther. 264, 1364-1376.
44. 1A agonist in traumatically brain injured patients. J. Neurotrauma 12, 1313-1321.
45. POLDERMAN, K.H., TJONG TJIN, J. R., PEERDEMAN, S.M., et al. (2002). Effects of therapeutic hypothermia on intracranial pressure and outcome in patients with severe head injury. Intensive Care Med. 28, 1563-1573.
46. 1A receptor agonists in rodent models of focal and global cerebral ischemia. Eur. J. Pharmacol. 203, 213-222.
47. PREHN, J.H., WELSCH, M., BACKHAUSS, C., et al. (1993). Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia. Brain Res. 630, 10-20.
48. RAITERI, M., MAURA, G., and BARZIZZA, A. (1991). Activation of presynaptic 5-hydroxytryptaminel-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices. J. Pharmacol. Exp. Ther. 257, 1184-1188.
49. SAKAUE, M., SOMBOONTHUM, P., NISHIHARA, B., et al. (2000). Postsynaptic 5-hydroxytryptamine (1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br. J. Pharmacol. 129, 1029-1034.
50. SCHEFF, S.W., BALDWIN, S.A., BROWN, R.W., et al. (1997). Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact. J. Neurotrauma 14, 615-627.
51. SEMKOVA, I., WOLZ, P., and KRIEGLSTEIN, J. (1998). Neuroprotective effect of 5-HT1A receptor agonist, Bay × 3702, demonstrated in vitro and in vivo. Eur. J. Pharmacol. 359, 251-260.
52. SHAO, L., CIALLELLA, J.R., YAN, H.Q., et al. (1999). Differential effects of traumatic brain injury on vesicular acetylcholine transporter and M2 muscarinic receptor mRNA and protein in rat. J. Neurotrauma 16, 555-566.
53. SMITH, D.H., OKIYAMA, K., THOMAS, M.J., et al. (1991). Evaluation of memory dysfunction following experimental brain injury using the Morris water maze. J. Neurotrauma 8, 259-269.
54. SQUIRE, L.R. and DAVIS, H.P. (1981). The pharmacology of memory: a neurobiological perspective. Annu. Rev. Pharmacol. Toxicol. 21, 325-356.
55. TORUP, L., MØLLER, A., SAGER, T.N., et al. (2000). Neuroprotective effect of 8-OH-DPAT in global cerebral ischemia assessed by stereological cell counting. Eur. J. Pharmacol. 395, 137-141.
56. YAN, H.Q., YU, J., KLINE, A.E., et al. (2000). Evaluation of combined fibroblast growth factor-2 and moderate hypothermia therapy in traumatically brain injured rats. Brain Res. 887, 136-145.